http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1429935-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d709e3167fa2f99a1803c9cfeb0aca63
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H15-252
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C46-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C67-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D407-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H15-252
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C50-38
filingDate 1984-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 1988-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c767a026f7b2e6909e55da35f2c92dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f75763e41db10adb88aa33f4bfe7777a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ef8b6eb86f32453a3ab3c0d7465420aa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e9f5c461116d64b7a6a280ff9546288
publicationDate 1988-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber SU-1429935-A3
titleOfInvention Method of producing 6 - deoxyanthracyclineglycosides
abstract A new process for the preparation of 6-deoxyanthracyclinones of general formula I: <IMAGE> I wherein R represents a hydrogen atom, a hydroxy group or a lower alkoxy group is described. The process provides a total synthesis of the 6-deoxyanthracyclinones of formula I using 1,2,3,6-tetrahydro-phthalate as starting material. The obtained racemic mixture of the compounds of formula I, if desired, can be submitted to optical resolution by the conventional method of conversion to diastereomeric derivatives using a chiral resolving agent. Alternatively, the racemic mixture can be used as such for the condensation with a suitably protected halosugar derivative to obtain alpha glycosidic derivatives of formula XV: <IMAGE> XV wherein R1 represents a hydrogen atom or a hydroxy group, one of R2 and R3 represents a hydrogen atom, the other of R2 and R3 represents a hydrogen atom or a hydroxy group and X is a hydrogen atom or a trifluoro acetyl group. The N-trifluoroacetyl 7S:9S and 7R:9R derivatives of the alpha -glycosides of formula XV can be separated by chromatography on silica gel to obtain, after mild alkaline hydrolisis the wanted 7S:9S alpha -glycosides (R1=H) as free bases and can eventually be transformed into their corresponding doxorubicin derivatives (R1=OH) by known procedures.
priorityDate 1983-06-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2723810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535365
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21953482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1268256
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559095
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6570
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID76223
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419514518
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24261
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6344
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457707758
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449392513
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416115865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419699759
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457282502
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454007247
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408671671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393336
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18914200
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31703
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587

Total number of triples: 60.